<--- Back to Details
First PageDocument Content
Cardiac electrophysiology / Pharmaceutical industry / Medicine / Implanted cardiac resynchronization device / Clinical endpoint / Artificial cardiac pacemaker / Adverse event / Clinical trial / Cardiology Trials Quick Review / Clinical research / Science / Research
Date: 2004-07-27 11:26:57
Cardiac electrophysiology
Pharmaceutical industry
Medicine
Implanted cardiac resynchronization device
Clinical endpoint
Artificial cardiac pacemaker
Adverse event
Clinical trial
Cardiology Trials Quick Review
Clinical research
Science
Research

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 287,50 KB

Share Document on Facebook

Similar Documents

Print Form Alabama Board of Medical Examiners P.O. Box 946, Montgomery, ALOffice-Based Surgery Adverse Event Report Form

DocID: 1vm7X - View Document

Washington University in St. Louis Institutional Biological & Chemical Safety Committee Policy on Severe Adverse Event Reporting for Human Gene Therapy Trials As outlined in Section IV-B-2-b-(1) of the NIH Guidelines for

DocID: 1vily - View Document

National Action Plan for Adverse Drug Event Prevention

DocID: 1v1KN - View Document

Microsoft Word - FINAL-Formatted-University Adverse Weather and Emergency Event Policy -eff

DocID: 1uZd2 - View Document

National Action Plan for Adverse Drug Event Prevention

DocID: 1uxaR - View Document